A prospective,multi-center,parallel-group comparison study to evaluate safety and efficacy of dabigatran during the perioperative period in patients with non-valvular atrial fibrillation who undergo the catheter ablation compared to walfarin
Phase of Trial: Phase III
Latest Information Update: 12 Jul 2017
Price : $35 *
At a glance
- Drugs Dabigatran etexilate (Primary) ; Warfarin
- Indications Embolism
- Focus Therapeutic Use
- Acronyms ABRIDGE-J
- 10 Jul 2017 Status changed from active, no longer recruiting to completed.
- 12 Feb 2017 Planned number of patients changed from 1000 to 450.
- 11 Jun 2014 Planned End Date changed to 31 Aug 2016 as reported by University Hospital Medical Information Network - Japan.